Amgen, Mass General, Broad Institute Collaborate on New Drugs for IBD
January 15, 2014 at 09:18 AM EST
Massachusetts General Hospital (MGH), the Broad Institute, and Amgen (NASDAQ: AMGN ) announced today that they have launched a strategic collaboration to jointly discover and validate new therapeutic targets and develop novel therapies for inflammatory bowel disease (IBD), a chronic disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration brings